Seelos Therapeutics, Inc. Derivative Liability
Seelos Therapeutics, Inc. had Derivative Liability of $1.17 million as of 2021-12-31, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2022-11-10
- 2021-12-31: Derivative Liability $1.17M.
- 2019-09-30: Derivative Liability $690.00K.
- 2019-06-30: Derivative Liability $1.10M.
- 2019-03-31: Derivative Liability $4.46M.
| Period end | Derivative Liability |
|---|---|
| 2021-12-31 | $1.17M 10-Q · filed 2022-11-10 |
| 2019-09-30 | $690.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.10M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $4.46M 10-Q · filed 2019-05-21 |